Safety and Efficacy of Aortic Root Reinforcement Combined With Vascular Grafts Eversion and built-in Procedure (XJ-procedure) in Patients With Acute Type A Aortic Dissection (ADVANCED-XJ )

Type A Aortic Dissection Clinical Trial

Official title:
Safety and Efficacy of Aortic Root Reinforcement Combined With Vascular Grafts Eversion and built-in Procedure (XJ-procedure) in Patients With Acute Type A Aortic Dissection (ADVANCED-XJ ): an Investigator-initiated, Single-center, Cohort Study

Status Completed

Clinical Trial Summary

This is a retrospective study based on the data available in our hospital database for ATAAD patients from January 2020 to December 2021. These patients were divided into two groups according to the surgical procedures of aortic root. This study compared baseline data, perioperative and short-term follow-up results between the two groups to evaluate the efficacy and safety of XJ-procedure in ATAAD.

Clinical Trial Description

Acute type A aortic dissection (ATAAD) is a life-threatening disease with high mortality. Surgery remains the gold standard for the treatment of ATAAD. In recent years, ATAAD is still a persistent challenge for cardiovascular surgeons. This is a retrospective study based on the data available in our hospital database for ATAAD patients undergoing total aortic arch replacement with elephant trunk stent under cryogenic stop circulation from January 2020 to December 2021. These patients were divided into two groups according to the surgical procedures of aortic root: continuous aortic root suture group (CARS group); "aortic root reinforcement combined with vascular grafts eversion and built-in", which was created by our group and to be named as XJ-procedure (XJ-procedure group, XJ is an acronym for Xi'an Jiaotong University). The main outcome was defined as 30-day mortality. Secondary outcomes included the postoperative bleeding necessitating re-operation and the incidence of anastomotic pseudoaneurysm, residual aortic root dissection and severe aortic regurgitation before discharge and at 3 and 6 months after the operation. This study compared baseline data, perioperative and short-term follow-up results between the two groups to evaluate the efficacy and safety of XJ-procedure in ATAAD. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05751200
Study type	Observational
Source	First Affiliated Hospital Xi'an Jiaotong University
Contact
Status	Completed
Phase
Start date	March 1, 2023
Completion date	March 2, 2023

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06199401` - Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery	N/A
Active, not recruiting	`NCT03369977` - BioGlue as an Adjunct for Structural Repair and Hemostasis in Chinese Acute Type A Aortic Dissections Patients	N/A
Completed	`NCT04711889` - Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Ulinastatin) II	N/A
Recruiting	`NCT03607786` - Antegrade Cerebral Perfusion and Retrograde Inferior Vena Caval Perfusion for Total Aortic Arch Replacement	N/A
Enrolling by invitation	`NCT05927090` - Outcomes of Type A Aortic Dissection Repair
Completed	`NCT05346497` - Surgical Management of the Aortic Root and Long-term Outcomes For Acute Type A Aortic Dissection
Active, not recruiting	`NCT04831073` - European Registry of Type A Aortic Dissection
Completed	`NCT02164201` - Post Market Surveillance Study Evaluating BioFoam Surgical Matrix in Cardiovascular Surgery	N/A
Recruiting	`NCT04032366` - iNO as Salvage Treatment of Hypoxemia After TAAD Surgery